Spectral AI highlights collaboration with leaders in burn care for DeepView

Spectral AI (MDAI) announced that national leaders in burn care have dedicated more than an estimated 511 in-person days of physician engagement to the training and validation studies for the DeepView System for U.S. Food and Drug Administration submission. This does not include more than an estimated 250 additional days that these experts devoted in Proof-of-Concept studies. The company said, “This extraordinary collaboration includes participation from physicians across the country who are national leaders in burn care. They include three current or former presidents, and ten board members/past board members of the national burn organization, the American Burn Association, and two editors-in-chief of leading medical burn journals. This level of participation by such esteemed professionals represents an unprecedented investment of time and expertise to work with Spectral AI’s team to develop artificial intelligence algorithm.”